David Pellman, MD, FAACR
AACR-G.H.A. Clowes Award for Outstanding Basic Cancer Research

David Pellman, MD, FAACR

Margaret M. Dyson Chair in Pediatric Oncology
Dana-Farber Cancer Institute;
Professor, Department of Cell Biology and Pediatrics
Harvard Medical School;
Investigator, Howard Hughes Medical Institute;
Associate Director for Basic Science
Dana-Farber/Harvard Cancer Center
Boston, MA

For pioneering work dedicated to identifying the mechanisms responsible for inducing structural and numerical chromosome aberrations in cancer. Dr Pellman has demonstrated through the development of brilliant murine models that whole genome duplication has the potential to accelerate somatic cancer evolution. This discovery and his demonstration that chromosome rearrangement may cause micronuclei formation resulting in chromothripsis has contributed to numerous subsequent studies dedicated to understanding the relationship between genome stability and cancer.

The AACR-G.H.A. Clowes Award for Outstanding Basic Cancer Research was established by the AACR and Eli Lilly and Co. in 1961 to honor Dr. G.H.A. Clowes, who was a founding member of the AACR and a research director at Eli Lilly. The award is intended to recognize an individual who has made outstanding recent accomplishments in basic cancer research. To learn more, please visit the press release.

View Dr. Pellman’s  Fellows of the AACR Academy page.

View Past Recipients